Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy

Abstract Cannabichromene (CBC: C21H3O2, M.W.: 314.46 g) is a non-psychotropic phytocannabinoid derived from Cannabis sativa (hemp), and its potential therapeutic properties have attracted increasing attention. Specifically, it has demonstrated strong anti-inflammatory effects in animal models of ede...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu-Na Hwang, Ju-Hee Park, Han-Heom Na, Tae-Hyung Kwon, Jin-Sung Park, Sehyun Chae, Young Taek Oh, Keun-Cheol Kim
Format: Article
Language:English
Published: Nature Publishing Group 2025-08-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02674-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387996450652160
author Yu-Na Hwang
Ju-Hee Park
Han-Heom Na
Tae-Hyung Kwon
Jin-Sung Park
Sehyun Chae
Young Taek Oh
Keun-Cheol Kim
author_facet Yu-Na Hwang
Ju-Hee Park
Han-Heom Na
Tae-Hyung Kwon
Jin-Sung Park
Sehyun Chae
Young Taek Oh
Keun-Cheol Kim
author_sort Yu-Na Hwang
collection DOAJ
description Abstract Cannabichromene (CBC: C21H3O2, M.W.: 314.46 g) is a non-psychotropic phytocannabinoid derived from Cannabis sativa (hemp), and its potential therapeutic properties have attracted increasing attention. Specifically, it has demonstrated strong anti-inflammatory effects in animal models of edema through non-CB receptor mechanisms; however, further pharmacological studies based on cancer models are required. In this study, we investigated the molecular mechanisms underlying the anti-cancer activity of CBC in human pancreatic cancer cells. Through mRNA-seq analysis, the expression levels of many genes involved in cell death pathways were upregulated or downregulated after CBC treatment, and these included ferroptosis-related genes, such as HMOX1. We further confirmed the functional validity of apoptosis and ferroptosis induction after CBC treatment using various molecular assays. In addition, CBC preferentially increased the expression of TRPV1 and CB2. Accordingly, the effects on cell death were reversed after treatment with TRPV1 and CB2 inhibitors, suggesting that receptor expression is necessary for the induction of apoptotic cell death. Finally, we confirmed the consistent regulation of apoptosis, ferroptosis, and endocannabinoid receptors during tumor growth inhibition after CBC treatment using in vivo xenograft models. Therefore, we propose that CBC exhibits pharmacological activity via the integrative modulation of multiple cell death pathways, which can be exploited for pancreatic cancer therapy.
format Article
id doaj-art-5662ce76514e42aeb4916d0b2eefdbd0
institution Kabale University
issn 2058-7716
language English
publishDate 2025-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-5662ce76514e42aeb4916d0b2eefdbd02025-08-20T03:42:26ZengNature Publishing GroupCell Death Discovery2058-77162025-08-0111111610.1038/s41420-025-02674-8Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapyYu-Na Hwang0Ju-Hee Park1Han-Heom Na2Tae-Hyung Kwon3Jin-Sung Park4Sehyun Chae5Young Taek Oh6Keun-Cheol Kim7Department of Biological Sciences, College of Natural Sciences, Kangwon National UniversityDepartment of Biological Sciences, College of Natural Sciences, Kangwon National UniversityDepartment of Biological Sciences, College of Natural Sciences, Kangwon National UniversityChuncheon Bioindustry FoundationKorean Pharmacopuncture InstituteDivision of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National UniversityDepartment of Biological Sciences, College of Natural Sciences, Kangwon National UniversityDepartment of Biological Sciences, College of Natural Sciences, Kangwon National UniversityAbstract Cannabichromene (CBC: C21H3O2, M.W.: 314.46 g) is a non-psychotropic phytocannabinoid derived from Cannabis sativa (hemp), and its potential therapeutic properties have attracted increasing attention. Specifically, it has demonstrated strong anti-inflammatory effects in animal models of edema through non-CB receptor mechanisms; however, further pharmacological studies based on cancer models are required. In this study, we investigated the molecular mechanisms underlying the anti-cancer activity of CBC in human pancreatic cancer cells. Through mRNA-seq analysis, the expression levels of many genes involved in cell death pathways were upregulated or downregulated after CBC treatment, and these included ferroptosis-related genes, such as HMOX1. We further confirmed the functional validity of apoptosis and ferroptosis induction after CBC treatment using various molecular assays. In addition, CBC preferentially increased the expression of TRPV1 and CB2. Accordingly, the effects on cell death were reversed after treatment with TRPV1 and CB2 inhibitors, suggesting that receptor expression is necessary for the induction of apoptotic cell death. Finally, we confirmed the consistent regulation of apoptosis, ferroptosis, and endocannabinoid receptors during tumor growth inhibition after CBC treatment using in vivo xenograft models. Therefore, we propose that CBC exhibits pharmacological activity via the integrative modulation of multiple cell death pathways, which can be exploited for pancreatic cancer therapy.https://doi.org/10.1038/s41420-025-02674-8
spellingShingle Yu-Na Hwang
Ju-Hee Park
Han-Heom Na
Tae-Hyung Kwon
Jin-Sung Park
Sehyun Chae
Young Taek Oh
Keun-Cheol Kim
Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
Cell Death Discovery
title Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
title_full Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
title_fullStr Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
title_full_unstemmed Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
title_short Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
title_sort cannabichromene integrative modulation of apoptosis ferroptosis and endocannabinoid signaling in pancreatic cancer therapy
url https://doi.org/10.1038/s41420-025-02674-8
work_keys_str_mv AT yunahwang cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT juheepark cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT hanheomna cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT taehyungkwon cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT jinsungpark cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT sehyunchae cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT youngtaekoh cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy
AT keuncheolkim cannabichromeneintegrativemodulationofapoptosisferroptosisandendocannabinoidsignalinginpancreaticcancertherapy